ORLADEYO net revenue expected to be between $515-$535 million in 2025— —Total revenue (including RAPIVAB®) expected to be ...
E2open Parent Holdings, Inc. (NYSE: ETWO) ("e2open" or the "Company"), the connected supply chain SaaS platform with the ...
39mon MSN
Innovations in the auto, aerospace sectors and medtech industry has helped TCS secure a good number of large deals in the ...
Novel Self-Assembly DisAssembly Pre-targeted Radioimmunotherapy (“SADA PRIT”) platform designed to improve upon traditional radioimmunotherapy by delivering high therapeutic dose while minimizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback